Cause of death, by non-communicable diseases, female in Iran
Iran: Cause of death, by non-communicable diseases, female was 63.9% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, female in Iran, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths.
Analysis
In 2021, cause of death, by non-communicable diseases, female in Iran stood at 63.9%. That is the lowest value across all 6 years on record.
The figure is down 7.7% on the previous year and down 21.6% over ten years.
Over the whole period, cause of death, by non-communicable diseases, female in Iran peaked at 88.6% in 2019 and was at its lowest, 63.9%, in 2021.
Iran ranks 112th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, female in Iran, year by year
| Year | % of total female deaths | Change |
|---|---|---|
| 2000 | 75.4% | — |
| 2010 | 81.5% | +8.2% |
| 2015 | 86.1% | +5.6% |
| 2019 | 88.6% | +2.8% |
| 2020 | 69.3% | -21.8% |
| 2021 | 63.9% | -7.7% |
Iran compared with similar countries
- Iran's 63.9% is below the median for upper middle income countries, which is 70.0%, 91% of the median. (55 countries reporting)
- Iran's 63.9% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 68.4%, 93% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 75.4% | 75.4% | 75.4% | 1 |
| 2010s | 85.4% | 81.5% | 88.6% | 3 |
| 2020s | 66.6% | 63.9% | 69.3% | 2 |
Countries ranked near Iran
- 109 Kazakhstan 64.9% compare
- 110 Kyrgyzstan 64.1% compare
- 111 Argentina 64.0% compare
- 113 Tajikistan 63.8% compare
- 114 Bahamas 63.2% compare
- 115 Jordan 62.7% compare
More health data for Iran
- Un projection of annual infant deaths, annual growth rate -1.38 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5627 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,361 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,070 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.88 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0311 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.95 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, female in Iran?
- Cause of death, by non-communicable diseases, female in Iran was 63.9% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, female recorded in Iran?
- The highest recorded value was 88.6% in 2019.
- What is the lowest cause of death, by non-communicable diseases, female recorded in Iran?
- The lowest recorded value was 63.9% in 2021.
- How does Iran rank for cause of death, by non-communicable diseases, female?
- Iran ranks 112th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, female rising or falling in Iran?
- Over the last ten years it is down 21.6%. The long-run trend across the full record is falling.
- Where does this Iran data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.